Diabetic peripheral neuropathic pain: Case studies

Mayo Clinic Proceedings

Volumn 81, Issue 4 SUPPL., 2006, Pages

  Belgrade, Miles J ^a   Cole, B Eliot ^b   McCarberg, Bill H ^c   McLean, Michael J ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b American Society of Pain Educators   (United States)

^c KAISER PERMANENTE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; DULOXETINE; FLUOXETINE; GABAPENTIN; IBUPROFEN; LIDOCAINE; OXYCODONE; PARACETAMOL; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ANALGESIA; ANTICHOLINERGIC EFFECT; ARTICLE; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRY EYE; FATIGUE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MEMORY DISORDER; NAUSEA; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; QUALITY OF LIFE; SIDE EFFECT; STOMACH DISCOMFORT; TREATMENT OUTCOME; URINARY HESITANCY; XEROSTOMIA;

EID: 33645688136     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(11)61476-6     Document Type: Article

References (24)

1. Boulton AJM. Management of diabetic peripheral neuropathy. Clin Diabetes. 2005;23:9-15.
2. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study [published correction appears in Neurology. 1993;43:2345]. Neurology. 1993;43:817-824.
3. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37:589-596.
4. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991;45:3-9.
5. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-1256.
6. Gomez-Perez FJ, Choza R, Rios JM, et al. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res. 1996;27:525-529.
7. Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75:234-241.
8. Neurontin [prescribing information]. New York, NY: Parke-Davis Division of Pfizer Inc; 2005.
9. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831-1836.
10. Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin. 2004;20(suppl 2):S21-S2S.
11. Barbano RL, Herrmann DN, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA, Dworkin RH, Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy, Arch Neurol. 2004;61:914-918.
12. Cymbalta [prescribing information]. Indianapolis, Ind; Eli Lilly and Company; 2005.
13. Lyrica [prescribing information]. New York, NY: Pfizer; 2005.
14. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116:109-118.
15. Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized, multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005;6:346-356.
16. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110:628-638.
17. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004;63:2104-2110.
18. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60:927-934.
19. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105:71-78.
20. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842-1846.
21. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458-1486.
22. Barbano R, Hart-Gouleau S, Pennella-Vaughan J, Dworkin RH. Pharmacotherapy of painful diabetic neuropathy. Curr Pain Headache Rep. 2003;7:169-177.
23. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217-227.
24. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study [published correction appears in Pain. 2005;113:248]. Pain. 2004;110:697-706.